Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Ravi MB, Srinivas S, Silina E, Sengupta S, Tekwani T, Achar RR (2022) Prosthetic rehabilitation of rhino orbital mucormycosis associated with COVID-19: a case series. Clin CosmetInvestig Dent 14:1–10
2. Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15(4):102146. https://doi.org/10.1016/j.dsx.2021.05.019
3. Rao VUS, Arakeri G, Madikeri G, Shah A, Oeppen RS, Brennan PA (2021) COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Br J Oral Maxillofac Surg 59(9):1095–1098. https://doi.org/10.1016/j.bjoms.2021.06.013
4. Ray I, Bardhan M, Hasan MM, Sahito AM, Khan E, Patel S, Jani I, Bhatt PK, Sp R, Swed S (2022) Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic. Ann Med Surg (Lond) 78:103797
5. Jeong W et al (2019) The epidemiology and clinical manifestations of mucormycosis: a systematic review and metaanalysis of case reports. Clin Microbiol Infect 25:26–34